This section is not available in the published analysis.
Recce Pharmaceuticals Ltd: Audience
Recce Pharmaceuticals is developing a new class of synthetic anti-infectives aimed at combating antibiotic-resistant superbugs. Their innovative solutions target difficult-to-treat bacterial infections with a universal mechanism of action.